Furthermore, JMJD3 inhibition improved necrotizing enterocolitis (NEC) by attenuating the inflammatory response and ameliorating intestinal injury via the NF-κB and JAK2/STAT3 pathways in NEC mice [59]. The gene discussed is KDM6B; the disease is necrotizing enterocolitis.